memory
| 4 min read
Alzheimer's disease blood tests, FDA rejections, and more led the news this week.
| 3 min read
Novo Nordisk’s Phase 3 trials revealed that oral semaglutide failed to slow the progression of disease.
| 3 min read
Cannabigerol relieved anxiety and stress without the psychoactive effects of THC in a small clinical trial.
| 5 min read
Chemotherapy patients have reported cognitive impairments known as “chemobrain.” Now, researchers are closer to finding its cause and a potential treatment.
| 3 min read
Activating specific neurons using light helped scientists establish a causal link between improved sleep and diminished signs of Alzheimer’s disease in mice.
| 10 min read
Researchers explore the role of forgetting in normal brain function and as a therapeutic target for fear-related disorders.
| 2 min read
A dementia-associated tau mutation promotes unusual clustering of Fyn, a protein important for learning and memory.
| 4 min read
Data from a highly resilient individual guided researchers to new potential therapeutic targets.
| 2 min read
Researchers identified a component of cerebrospinal fluid that improved memory in old mice, potentially opening the door to drug development.
Page 1 of 1 - 9 Total Items
